-
Product Insights
Fazenda Imbe Field, Brazil
Fazenda Imbe upstream field is located in Bahia, Brazil. The upstream field is owned by Petroleo Brasileiro SA. It is operated by Petroleo Brasileiro SA. The project started its operations in 1964. Fazenda Imbe Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves and capital and operating costs. We also provide...
-
Product Insights
Rotkreuzhof Imb – Chaesimatt Mixed-Use Development – Zug
Equip yourself with the essential tools needed to make informed and profitable decisions with our Rotkreuzhof Imb - Chaesimatt Mixed-Use Development - Zug report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
A Silva & Silva Imb – Seixal Baia Residential Complex – Setubal
Equip yourself with the essential tools needed to make informed and profitable decisions with our A Silva & Silva Imb - Seixal Baia Residential Complex - Setubal report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Imbed Biosciences Inc Pipeline Insight and Competitive Landscape, 2023
Imbed Biosciences Inc (Imbed) operates as a medical device company that develops technologies for imbedding bioactive molecules in wound dressings and surgical implants. The company’s polymeric microfilm product platform develops bioactive molecules on tissue surfaces to manage wound infections, biofilms, and local pain and support wound healings. It conducts research for the development of antibacterial, antibiofilm and analgesic wound dressings. Imbed’s antibiofilm wound dressing is an ultra-thin transparent film wound dressings made with polymeric films containing silver nanoparticles. The company’s...
-
Product Insights
Transmucosal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transmucosal Drug Delivery Pipeline Market Report Overview A Transmucosal drug delivery device is intended for the localized delivery of medications through a mucous membrane. The transmucosal drug delivery pipeline market research report provides comprehensive information about the transmucosal drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segment ·      Nasal ·      Vaginal ·      Buccal Delivery ·      Rectal Key Territories ·      The US...
-
Company Profile
Chart Industries Inc – Company Profile
Chart Industries Inc (Chart) is a manufacturer of engineered equipment. It designs and manufactures engineered cryogenic equipment used in the liquid gas supply value chain. The company’s product offerings include vacuum insulated containment vessels, cold boxes, liquefaction process units, heat exchangers, other cryogenic components, ambient temperature fans and equipment, and gas processing equipment. Chart’s products are used in production, purification, liquefaction, storage, distribution and end-use of atmospheric, hydrocarbon, and industrial gases. It markets the products under the brand names Air-X-Changers,...
Add to Basket -
Company Profile
Inphi Corporation – Company Profile
Inphi Corporation (Inphi) a subsidiary of Marvell Technology Group Ltd, offers analog semiconductor solutions. The company's products portfolio includes modulator drivers, transimpedance amplifiers, coherent digital signal processor, ColorZ for DWDM, pulse amplitude modulation (PAM) and PHY / SerDes. It offers 25G to 600G high-speed analog and mixed signal semiconductor solutions for the communications market. Inphi provides products under the brands Inphi, ColorZ-Lite, iMB, Polaris, Tri-rate and ColorZ. The company markets its products to communications and data center markets. It operates...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – IMB-110
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry IMB-110 Drug Details IMB-110 is under development for the treatment of chronic low back...
-
Product Insights
Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
According to the recently published report 'Nociceptin Receptor – Drugs In Development, 2022'; Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) pipeline Target constitutes close to 15 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) – Nociceptin receptor also known as the nociceptin or orphanin FQ receptor or kappa-type-3 opioid...
-
Product Insights
Autism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Autism, also known as a complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication, and repetitive behaviors. Risk factors include the child’s sex, family history, fragile X syndrome, Tourette syndrome, and epilepsy. Treatment includes SSRIs (selective serotonin reuptake inhibitors), antidepressants, antipsychotics, and sedatives. The Autism drugs in development market research report provides comprehensive information on the therapeutics under development for Autism, complete with analysis by stage of development, drug target, mechanism of action (MoA),...